Back to FMS
Fresenius Medical Care, N.A. Has Selected VitalRemedyMD's VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients

BOCA RATON, Fla., Oct. 9 /PRNewswire/ -- VitalRemedyMD, a physician-established company, offers scientifically formulated integrative nutritional supplements designed to improve the quality of traditional healthcare. "We are proud that VitalProteinRx is now an integral part of Fresenius' armamentarium in helping patients with chronic kidney disease," stated Dr. Seth Baum, Founder of VitalRemedyMD. A state-of-the-art medical food, VitalProteinRx is designed to provide highly concentrated quality protein for patients on dialysis and those with diabetes. Protein malnutrition is a major problem facing dialysis patients. These patients often develop taste disorders, anorexia, and an aversion to meat, all of which put them at risk for severe protein malnutrition and other nutritional deficiencies. The use of protein supplementation can significantly reduce the risk of protein malnutrition and may help improve overall patient outcomes.

About VitalRemedyMD:

VitalRemedyMD was founded by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA, a leading and practicing preventive cardiologist and cholesterol expert, to offer integrative nutritional supplements designed to improve the quality of traditional healthcare. Scientifically assessed by independent, FDA-registered laboratories, VitalRemedyMD supplements are continuously assayed for quality, quantity and purity. By drawing from the most prestigious scientific and medical journals, in combination with clinical experience and expertise, VitalRemedyMD is able to create scientifically sound nutritional supplements. For more information, please visit http://www.myvitalremedymd.com/order/Homepg.htm

    Press Contact:

    Michael Schuster
    561-347-6446 ext 205
    mschuster@vitalremedymd.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE VitalRemedyMD

Copyright (2009) PR Newswire. All Rights Reserved.
Back to FMS
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki